These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 1330049)

  • 1. Differences in the biological activity of TNF alpha and TNF beta correlate with their different abilities for binding to the target cells.
    Kircheis R; Milleck J; Korobko VG; Shingarova LN; Schmidt HE
    Eur Cytokine Netw; 1992; 3(4):381-90. PubMed ID: 1330049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the differing effects of tumor necrosis factor and lymphotoxin on the growth of several human tumor lines.
    Browning J; Ribolini A
    J Immunol; 1989 Sep; 143(6):1859-67. PubMed ID: 2550545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological activity of mutants of human tumour necrosis factor-alpha.
    Kircheis R; Milleck J; Korobko VG; Shingarova LN; Behnke D; Schmidt HE
    Immunology; 1992 Jul; 76(3):433-8. PubMed ID: 1526652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic interactions of interleukin 1, interferon-beta, and tumor necrosis factor in terminally differentiating a mouse myeloid leukemic cell line (M1). Evidence that interferon-beta is an autocrine differentiating factor.
    Onozaki K; Urawa H; Tamatani T; Iwamura Y; Hashimoto T; Baba T; Suzuki H; Yamada M; Yamamoto S; Oppenheim JJ
    J Immunol; 1988 Jan; 140(1):112-9. PubMed ID: 3275716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human TNF mutants with selective activity on the p55 receptor.
    Van Ostade X; Vandenabeele P; Everaerdt B; Loetscher H; Gentz R; Brockhaus M; Lesslauer W; Tavernier J; Brouckaert P; Fiers W
    Nature; 1993 Jan; 361(6409):266-9. PubMed ID: 8380906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological activities of human tumor necrosis factor-alpha and its novel mutants.
    Xi T; Shi X; Guo D; Dong X; Xu X; Zhu D
    Biochem Mol Biol Int; 1996 Apr; 38(4):855-62. PubMed ID: 8728116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship of receptor occupancy to the kinetics of cell death mediated by tumor necrosis factor.
    Coffman FD; Green LM; Ware CF
    Lymphokine Res; 1988; 7(4):371-83. PubMed ID: 2850412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in the bioactivity of recombinant human TNF, LT, and T-cell-derived LT-3 on transformed cells in vitro and the Meth A tumor growing in BALB/c mice.
    Granger GA; Masunaka I; Averbook B; Kobayashi M; Fitzgerald M; Yamamoto R
    J Biol Response Mod; 1988 Oct; 7(5):488-97. PubMed ID: 3263472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphotoxin and TNF differ greatly in capacity to induce differentiation of human myeloblastic leukemia ML-1 cells.
    Takeda K; Iwamoto S; Takeda M
    Biochem Mol Biol Int; 1994 Apr; 32(6):1109-19. PubMed ID: 8061628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics of receptor-mediated uptake and processing of interferon-alpha 2a and tumor necrosis factor-alpha by human tumor cells.
    Dunne SL; Bajzer Z; Vuk-Pavlović S
    Growth Factors; 1990; 2(2-3):167-77. PubMed ID: 2160259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the receptor for tumor necrosis factor (TNF) and lymphotoxin (LT) on human T lymphocytes. TNF and LT differ in their receptor binding properties and the induction of MHC class I proteins on a human CD4+ T cell hybridoma.
    Andrews JS; Berger AE; Ware CF
    J Immunol; 1990 Apr; 144(7):2582-91. PubMed ID: 1969453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological activities of human tumor necrosis factor-alpha and its novel mutants.
    Xi T; Shi X; Guo D; Dong X; Xu X; Zhu D
    Biochem Mol Biol Int; 1996 May; 38(6):1183-9. PubMed ID: 8739040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of 55- and 75-kDa tumor necrosis factor membrane receptors in the regulation of intercellular adhesion molecules-1 expression by HL-60 human promyelocytic leukemia cells in vitro.
    Abe Y; Gatanaga M; Osuka Y; Kimura S; Burger RA; Granger GA; Gatanaga T
    J Immunol; 1993 Jun; 150(11):5070-9. PubMed ID: 8098725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the in vitro and in vivo species preference of human and murine tumor necrosis factor-alpha.
    Kramer SM; Aggarwal BB; Eessalu TE; McCabe SM; Ferraiolo BL; Figari IS; Palladino MA
    Cancer Res; 1988 Feb; 48(4):920-5. PubMed ID: 2827889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of colony-stimulating factor-1 receptors on macrophages by tumor necrosis factor.
    Shieh JH; Peterson RH; Warren DJ; Moore MA
    J Immunol; 1989 Oct; 143(8):2534-9. PubMed ID: 2551961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of combinations of transforming growth factor-beta 1 and tumor necrosis factor on induction of differentiation of human myelogenous leukemic cell lines.
    Kamijo R; Takeda K; Nagumo M; Konno K
    J Immunol; 1990 Feb; 144(4):1311-6. PubMed ID: 2105994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin 4 potentiates the antiproliferative effects of tumor necrosis factor on various tumor cell lines.
    Totpal K; Aggarwal BB
    Cancer Res; 1991 Aug; 51(16):4266-70. PubMed ID: 1651157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis factor alpha and interleukin 11 secreted by malignant breast epithelial cells inhibit adipocyte differentiation by selectively down-regulating CCAAT/enhancer binding protein alpha and peroxisome proliferator-activated receptor gamma: mechanism of desmoplastic reaction.
    Meng L; Zhou J; Sasano H; Suzuki T; Zeitoun KM; Bulun SE
    Cancer Res; 2001 Mar; 61(5):2250-5. PubMed ID: 11280794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural killer-sensitive targets stimulate production of TNF-alpha but not TNF-beta (lymphotoxin) by highly purified human peripheral blood large granular lymphocytes.
    Peters PM; Ortaldo JR; Shalaby MR; Svedersky LP; Nedwin GE; Bringman TS; Hass PE; Aggarwal BB; Herberman RB; Goeddel DV
    J Immunol; 1986 Oct; 137(8):2592-8. PubMed ID: 3760569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of type I IFN and IFN-gamma on the binding of tumor necrosis factor to receptors in two human cell lines.
    Tsujimoto M; Feinman R; Vilcek J
    J Immunol; 1986 Oct; 137(7):2272-6. PubMed ID: 3020123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.